Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Bioorganic & Medicinal Chemistry Letters|May 24, 2005
In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisineJotham W Coe, Michael G Vetelino, Crystal G Bashore, et al.
International Immunopharmacology|June 9, 2023
Caffeic acid phenethyl ester analogues as selective inhibitors of 12-lipoxygenase product biosynthesis in human plateletsMathieu P A Hébert, Ayyoub Selka, Andréa A Lebel, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2005
3,5-Bicyclic aryl piperidines: a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessationJotham W Coe, Paige R Brooks, Michael C Wirtz, et al.
Scoliosis|June 1, 2010
7th SOSORT consensus paper: conservative treatment of idiopathic & Scheuermann's kyphosisJc de Mauroy, Hr Weiss, Ag Aulisa, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 22, 2008
Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophreniaC J Schmidt, D S Chapin, J Cianfrogna, et al.
Journal of Medicinal Chemistry|May 13, 2005
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessationJotham W Coe, Paige R Brooks, Michael G Vetelino, et al.
Mayo Clinic Proceedings|March 3, 2010
Recommendations for the pharmacological management of neuropathic pain: an overview and literature updateRobert H Dworkin, Alec B O'Connor, Joseph Audette, et al.
Pageof 7